AbbVie Inc. (LON:0QCV)
185.44
-1.22 (-0.65%)
At close: Jun 27, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Immunology | 26.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Immunology Growth | 6.39% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology | 6.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology Growth | 9.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Key Products | 3.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Key Products Growth | -5.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
All Other | 3.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
All Other Growth | -1.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neuroscience | 9.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neuroscience Growth | 16.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Women's Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Women's Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Aesthetics | 5.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Aesthetics Growth | -4.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eye Care | 2.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eye Care Growth | -5.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 43.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 5.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International | 13.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
International Growth | 5.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|